UTMD (Utah Medical Products Inc) Stock Analysis - SEC Filings

Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find UTMD SEC filings?

Rallies organizes UTMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

UTMD Key Metrics

Key financial metrics for UTMD
MetricValue
Price$64.17
Market Cap$203.78M
P/E Ratio19.03
EPS$3.38
Dividend Yield0.31%
52-Week High$71.81
52-Week Low$51.26
Volume0
Avg Volume0
Revenue (TTM)$37.53M
Net Income$10.85M
Gross Margin57.94%

Latest UTMD News

Recent UTMD Insider Trades

  • RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
  • RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
  • RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.

UTMD Analyst Consensus

UTMD analyst coverage data. Average price target: $0.00.

Common questions about UTMD

Where can I find UTMD SEC filings?
Rallies organizes UTMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show UTMD 10-K and 10-Q filings?
Rallies organizes UTMD SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
UTMD

UTMD